WHO plan on fake medicines could signal retreat from IMPACT
This article was originally published in SRA
In a move that could herald a reduction in the World Health Organization's controversial involvement in the IMPACT anti-counterfeiting initiative, the body is to set up a new, member state-run mechanism to tackle the problem of substandard, falsified and counterfeit medicines1.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.